AOX1(aldehyde oxidase 1), a broad-spectrum oxidase, has demonstrated potential as a biomarker in various cancers, where its low expression in clear cell renal cell carcinoma and prostate cancer correlates with poor prognosis, suggesting its tumor-suppressing capabilities (76, 77). Here, AOX1 is linked to clear cell renal carcinoma.